Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack

By HospiMedica International staff writers
Posted on 05 Feb 2026

Cancer patients who experience a heart attack face a uniquely dangerous combination of risks, including higher chances of death, bleeding, and repeat cardiac events. More...

Because of this complexity, they have often been excluded from clinical trials and standard cardiovascular risk scores, leaving clinicians without clear guidance. This gap has made treatment decisions particularly difficult and inconsistent. A new study now shows that integrating cancer-specific factors with cardiovascular data can significantly improve risk prediction and treatment decisions for this vulnerable group.

An international team of researchers, led by the University of Zurich (Zurich, Switzerland), has developed the first risk prediction model designed specifically for cancer patients who suffer a heart attack. The artificial intelligence (AI)-based tool combines traditional cardiovascular indicators with cancer-related variables, such as tumor characteristics and treatment-related risks, to better reflect the real-world clinical complexity of these patients.

The model, called ONCO-ACS, was created using artificial intelligence to predict three major outcomes within six months of a heart attack: death, major bleeding, and recurrent cardiovascular events. Rather than treating cancer and heart disease as separate conditions, the tool captures their interaction. This allows clinicians to better balance competing risks, particularly when deciding on invasive procedures or antiplatelet therapies.

The study analyzed data from more than one million heart attack patients in England, Sweden, and Switzerland, including over 47,000 patients with cancer. Results showed that outcomes in cancer patients were markedly worse, with nearly one in three dying within six months and high rates of bleeding and recurrent events. The findings, published in The Lancet, demonstrated that ONCO-ACS significantly improves individualized risk prediction compared with existing tools.

The findings highlight the close biological and clinical link between cancer and cardiovascular disease. By providing a validated, personalized risk assessment, ONCO-ACS can help doctors determine which patients are likely to benefit from aggressive treatment and which face greater harm. The researchers aim to integrate the tool into routine clinical practice and use it to guide catheter-based interventions, antiplatelet therapy, and the design of future clinical trials focused on cancer patients with heart attacks.

“By accounting for both cancer and heart disease, ONCO-ACS marks a step towards truly personalized medicine,” said senior author Professor Thomas F. Lüscher. “It can help doctors decide who benefits from invasive procedures and intensive drug therapy, and who may be at greater risk of harm.”

Related Links:
University of Zurich


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.